References
- Apple FS, Ler R, Murakami MA. (2012). Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 58:1574–81
- Giannitsis E, Steen H, Kurz K, et al. (2008). Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol 51:307–14
- Hallén J. (2012). Troponin for the estimation of infarct size: what have we learned? Cardiology 121:204–12
- Hassan AK, Bergheanu SC, Hasan-Ali H, et al. (2009). Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention. Am J Cardiol 103:779–84
- Karavidas AJ, Vrachatis AD, Alpert MA, et al. (2002). Relation of troponin T release kinetics to long-term clinical outcome in patients with acute ST segment elevation myocardial infarction treated with a percutaneous intervention. Catheter Cardiovasc Interv 56:312–19
- Kavsak PA, Ko DT, Wang X, et al. (2010). Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain cohort. Clin Chem 56:1902–4
- Ottervanger JP, Armstrong P, Barnathan ES, et al. (2003). Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina. One-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV-Acute Coronary Sydrome) trial. Circulation 107:437–42
- Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. (2008). Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–72
- Reichlin T, Twerenbold R, Maushart C, et al. (2013). Risk stratification in patients with unstable angina using absolute serial changes of 3 high-sensitive troponin assays. Am Heart J 165:371–8.e3
- Simoons ML, GUSTO IV-ACS Investigators. (2001). Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early revascularisation: the GUSTO IV-ACS randomised trial. Lancet 357:1915–24
- Tarantini G, Razzolini R, Cacciavillani L, et al. (2006). Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty. Am J Cardiol 98:1033–40
- Thygesen K, Alpert JS, Jaffe AS, et al. (2012). Third universal definition of myocardial infarction. Circulation 126:2020–35